Dr Diana Schuhmacher

Selected publications

2025
Molecular Cancer Therapeutics10.1158/1535-7163.MCT-24-0704
Integration of whole genome sequencing analysis with unique patient-derived models reveals clinically relevant drug targets in TFCP2 fusion-defined rhabdomyosarcoma.
Patrick Bergsma, Sean Porazinski, Aji Istadi, Diego Chacon-Fajardo, Yasir Mahmood, Silvia Lombardi, Diana Schuhmacher, Henry Barraclough-Franks, Dario Strbenac, Claude V Dennis, Payam Faizi-Sobbi, Emer Cahill, Vivek A Bhadri, Jeneffer De Almeida Silva, Trina Lum, James Wykes, Timothy Manzie, Carsten E Palme, Jean Y H Yang, Jonathan R Clark, Ruta Gupta, Marina Pajic